Company · CIK 0001849011
Apeiron Capital Investment Corp.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13GApeiron Capital Investment Corp.0001104659-24-022606 · 48.9 KBSEC(opens sec.gov)
- SC 13G/AApeiron Capital Investment Corp.0001214659-24-000548 · 74.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-090537 · 211.1 KBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-23-001210 · 4.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-058654 · 382.4 KBSEC(opens sec.gov)
- 10-KAnnual report0001410578-23-000413 · 5.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-032346 · 1.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-030258 · 267.5 KBSEC(opens sec.gov)
- SC 13GApeiron Capital Investment Corp.0001085146-23-001186 · 44.9 KBSEC(opens sec.gov)
- SC 13G/AApeiron Capital Investment Corp.0001062993-23-003207 · 47.4 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
175 FEDERAL STREET SUITE 875
BOSTON, MA, 02110
mailing
175 FEDERAL STREET SUITE 875
BOSTON, MA, 02110
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies